Cargando…
H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis
Two classes of antiviral drugs, neuraminidase inhibitors and adamantanes, are approved for prophylaxis and therapy against influenza virus infections. A major concern is that antiviral resistant viruses emerge and spread in the human population. The 2009 pandemic H1N1 virus is already resistant to a...
Autores principales: | van der Vries, Erhard, Collins, Patrick J., Vachieri, Sebastien G., Xiong, Xiaoli, Liu, Junfeng, Walker, Philip A., Haire, Lesley F., Hay, Alan J., Schutten, Martin, Osterhaus, Albert D. M. E., Martin, Steve R., Boucher, Charles A. B., Skehel, John J., Gamblin, Steve J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447749/ https://www.ncbi.nlm.nih.gov/pubmed/23028314 http://dx.doi.org/10.1371/journal.ppat.1002914 |
Ejemplares similares
-
Multidrug Resistant 2009 A/H1N1 Influenza Clinical Isolate with a Neuraminidase I223R Mutation Retains Its Virulence and Transmissibility in Ferrets
por: van der Vries, Erhard, et al.
Publicado: (2011) -
Influenza Hemagglutinin and Neuraminidase Membrane Glycoproteins
por: Gamblin, Steven J., et al.
Publicado: (2010) -
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase
por: van der Vries, E., et al.
Publicado: (2010) -
A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014) -
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)
por: Roosenhoff, Rueshandra, et al.
Publicado: (2020)